Antares Pharma, Inc., a leading developer and marketer of parenteral pharmaceuticals, has dosed its first patient in a clinical study evaluating testosterone enanthate administered weekly by ...
Antares Pharma, Inc. has reported positive results from a multi-centre phase II clinical study evaluating the pharmacokinetic profile of testosterone enanthate administered once-weekly by subcutaneous ...
Antares Pharma, Inc. has announced positive results from a multi-center phase 2 clinical study evaluating the pharmacokinetic profile of testosterone enanthate administered once-weekly by subcutaneous ...
The auto injector market represents a rapidly expanding segment within the global pharmaceutical delivery systems industry, driven by the increasing prevalence of chronic diseases and the growing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback